FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post How different peptide therapies may affect your body Prenuvo blog When Systems Fail: Lessons from an FDA Warning Letter Drug Safety and Pharmacovigilance Course Analysis: The peptide problem: Hype is outrunning the evidence McMaster News